We protect the public and promote the safe and ethical delivery of quality medical care by registrants in Manitoba.
Phone: (204) 774-4344
Toll Free: (877) 774-4344
Email: cpsm@cpsm.mb.ca
May 16, 2024 |
Prescribing Practices

Are you an OAT Prescriber? Share your experience!

Participate in a brief interview about your experiences as an OAT Prescriber

November 20, 2023 |
Quality Prescribing Practices

Glucagon-like-peptide (GLP-1) receptor agonists and Anesthesia risks

An important message from Dr. Chris Christodoulou, Provincial Anesthesia Specialty Lead, Shared Health

October 13, 2023 |
Prescribing Practices

Rapid Access to Addictions Medicine Knowledge Exchange Days

Rapid Access to Addictions Medicine (RAAM) Knowledge Exchange Days are weekly virtual series taking place in Nov and Dec

September 20, 2023 |
Prescribing Practices

New Guidance: In-Hospital Prescribing of Methadone for Palliative Care Analgesia

New resource for prescribing methadone for analgesia in palliative care

August 24, 2023 |
Prescribing Practices

Public Consultation: Prescribing Requirements

A working group has updated and consolidated prescribing requirements into one Standard of Practice and one Practice Direction. Share your feedback!

New Recommended Practice Manual Launched to Support Opioid Agonist Therapy Prescribers in Manitoba

The Manitoba Opioid Agonist Therapy (OAT) Recommended Practice Manual was written by local experts and provides detailed guidance and expert recommendations for every aspect of OAT care.

Prescribing to Patients Whom You Have Not Assessed In-Person

The growing demand for certain drugs has raised concerns about prescribing to patients not assessed in-person

January 27, 2023 |
Prescribing Practices

Notice to all Prescribers: Manitoba Prescribing Practices Program (M3P) Update

Starting on February 15, 2023, physicians will not be required to complete the M3P form before prescribing medications on the M3P drug list. Read for more details.

January 23, 2023 |
Prescribing Practices

Manitoba Prescribing Practices Program (M3P) Reminder

Reminder to M3P prescribers regarding triplicate pad orders

October 06, 2022 |
Quality Prescribing Practices

Intravenous Ketamine Administration

Important update regarding the intravenous administration of ketamine in Manitoba

July 22, 2022 |
Prescribing Practices

Notice to M3P Prescribers: Upcoming Prescription Pad Changes

An important message on M3P prescription pad changes

March 28, 2022 |
Prescribing Practices

Tramadol Added to List of M3P Drugs

Effective March 31, Tramadol and all tramadol-containing products will now require an M3P approval to prescribe and will be subject to all M3P prescription requirements in Manitoba